CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1–positive regulator for tumor immune evasion
Journal of Clinical Investigation · 01.12.2023 · 133 (23)
DOI: 10.1172/jci167728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.12.2023. Verfasst von Shengnan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Tumor Escape, Lung Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIH.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
- Department of Physiology, School of Basic Medicine, Qingdao University, Qingdao, Shandong, China.
- State Key Laboratory of Proteomics, National Center of Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China.
- Department of Oral Maxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Oral Diseases, S…
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NIH
- National Natural Science Foundation of China
- Shandong Province Natural Science Foundation
- Dalian High-level Talent Innovation Support Program
Zitieren
APA
Wang, S., Iyer, R., Han, X., Wei, J., Li, N., Cheng, Y., Zhou, Y., Gao, Q., Zhang, L., Yan, M., Sun, Z., & Fang, D. (2023). CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1–positive regulator for tumor immune evasion. Journal of Clinical Investigation, 133(23). https://doi.org/10.1172/jci167728
Vancouver
Wang S, Iyer R, Han X, Wei J, Li N, Cheng Y, et al. CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1–positive regulator for tumor immune evasion. Journal of Clinical Investigation. 2023;133(23). doi:10.1172/jci167728
BibTeX
@article{Wang2023,
author = {Wang, Shengnan and Iyer, Radhika and Han, Xiaohua and Wei, Juncheng and Li, Na and Cheng, Yang and Zhou, Yuanzhang and Gao, Qiong and Zhang, Lingqiang and Yan, Ming and Sun, Zhaolin and Fang, Deyu},
title = {CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1–positive regulator for tumor immune evasion},
journal = {Journal of Clinical Investigation},
year = {2023},
volume = {133},
number = {23},
doi = {10.1172/jci167728}
}
EUVIMED